Radiology
-
Randomized Controlled Trial Comparative Study
Liver cancer: effects, safety, and cost-effectiveness of controlled-release oxycodone for pain control after TACE.
To evaluate the analgesic effect, safety, and cost-effectiveness of controlled-release oxycodone (CRO) to control postoperative pain in patients with liver cancer who are undergoing transarterial chemoembolization. ⋯ CRO is effective, safe, and cost-effective in the control of postoperative pain after transarterial chemoembolization for patients with inoperable liver cancer.